Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammatory Dry Eye Concept and Optimization of Cyclosporin A 0.05% Eyedrop Treatment
KCT0011519Phase 4Not yet recruiting
- Sponsor
- Yonsei University Health System
- Start
- Feb 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in dry eye syndrome (DED), sponsored by Yonsei University Health System. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0011519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011519.